Page last updated: 2024-12-08

knipholone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

knipholone: a binary compound of the anthraquinone chrysophanol and an acetylphloroglucinol [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

knipholone : An anthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 4 and 6, a methyl group at position 2 and a 3-acetyl-2,6-dihydroxy-4-methoxyphenyl group at position 1. It exhibits antioxidant, cytotoxic and antiplasmodial activities. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID442753
CHEMBL ID514883
CHEBI ID6141
SCHEMBL ID16226780
MeSH IDM0356652

Synonyms (10)

Synonym
knipholone
94450-08-5
chebi:6141 ,
CHEMBL514883
(+)-m-knipholone
1-(3-acetyl-2,6-dihydroxy-4-methoxyphenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione
1-(3-acetyl-2,6-dihydroxy-4-methoxyphenyl)-4,6-dihydroxy-2-methylanthracene-9,10-dione
DTXSID10331938
SCHEMBL16226780
Q15426245

Research Excerpts

Overview

Knipholone is an antiplasmodial phytocompound obtained from the roots of . It was found to be a selective inhibitor of leukotriene metabolism.

ExcerptReferenceRelevance
"Knipholone is an antiplasmodial phytocompound obtained from the roots of "( Multi-target molecular dynamic simulations reveal glutathione-S-transferase as the most favorable drug target of knipholone in
Abdalla, M; Abdullah Thagfan, F; Al-Shouli, ST; Almanaa, TN; Chetia, D; Sarma, M; Umar, AK; Zothantluanga, JH, 2023
)
2.56
"Knipholone was found to be a selective inhibitor of leukotriene metabolism in a human blood assay with an IC(50) value of 4.2microM."( Knipholone, a selective inhibitor of leukotriene metabolism.
Adams, M; Asres, K; Bauer, R; Bodensieck, A; Bucar, F; Gibbons, S; Streit, B; Wube, AA, 2006
)
2.5
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (5)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
antiplasmodial drugAn antiparasitic drug which is effective against Apicomplexan parasites in the genus Plasmodium. The genus contains over 200 species and includes those responsible for malaria.
leukotriene antagonistA drug designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level.
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (6)

ClassDescription
polyphenolMembers of the class of phenols that contain 2 or more benzene rings each of which is substituted by at least one hydroxy group.
methyl ketoneA ketone of formula RC(=O)CH3 (R =/= H).
methoxybenzenesAny aromatic ether that consists of a benzene skeleton substituted with one or more methoxy groups.
aromatic ketoneA ketone in which the carbonyl group is attached to an aromatic ring.
resorcinolsAny benzenediol in which the two hydroxy groups are meta to one another.
dihydroxyanthraquinone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (17)

Assay IDTitleYearJournalArticle
AID1304537Selectivity ratio of IC50 for human HeLa cells to IC50 for multidrug resistant Plasmodium falciparum NHP13372016Journal of natural products, Mar-25, Volume: 79, Issue:3
Identification of Compounds with Efficacy against Malaria Parasites from Common North American Plants.
AID1858849Antimalarial activity against Plasmodium falciparum NF54 by 96-well microtitre plate method based scintillation counting analysis2021European journal of medicinal chemistry, Jan-15, Volume: 210Antimalarial application of quinones: A recent update.
AID1062995Antiplasmodial activity against chloroquine-resistant ring stage Plasmodium falciparum Dd2 after 72 hrs by SYBR Green 1-based fluorescence assay2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Isolation of antiplasmodial anthraquinones from Kniphofia ensifolia, and synthesis and structure-activity relationships of related compounds.
AID356061Cytotoxicity against human HSC2 cells by MTT assay2003Journal of natural products, Jun, Volume: 66, Issue:6
Bulbinelonesides A-E, phenylanthraquinone glycosides from the roots of Bulbinella floribunda.
AID335831Antiplasmodial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 infected human erythrocytes after 48 hrs by [3H]hypoxanthine uptake2002Journal of natural products, Aug, Volume: 65, Issue:8
Gaboroquinones A and B and 4'-O-demethylknipholone-4'-O-beta-D-glucopyranoside, phenylanthraquinones from the roots of Bulbine frutescens.
AID1304532Antimalarial activity against multidrug sensitive Plasmodium falciparum HB3 assessed as growth inhibition after 72 hrs by SYBR Green based fluorescence assay2016Journal of natural products, Mar-25, Volume: 79, Issue:3
Identification of Compounds with Efficacy against Malaria Parasites from Common North American Plants.
AID335834Trypanocidal activity against Trypanosoma brucei rhodesiense STIB 900 after 72 hrs2002Journal of natural products, Aug, Volume: 65, Issue:8
Gaboroquinones A and B and 4'-O-demethylknipholone-4'-O-beta-D-glucopyranoside, phenylanthraquinones from the roots of Bulbine frutescens.
AID1304536Selectivity ratio of IC50 for human HeLa cells to IC50 for multidrug sensitive Plasmodium falciparum HB32016Journal of natural products, Mar-25, Volume: 79, Issue:3
Identification of Compounds with Efficacy against Malaria Parasites from Common North American Plants.
AID335832Antiplasmodial activity against multi drug-sensitive Plasmodium falciparum NF54 infected human erythrocytes after 48 hrs by [3H]hypoxanthine uptake2002Journal of natural products, Aug, Volume: 65, Issue:8
Gaboroquinones A and B and 4'-O-demethylknipholone-4'-O-beta-D-glucopyranoside, phenylanthraquinones from the roots of Bulbine frutescens.
AID335835Cytotoxicity against rat L6 cells after 4 days2002Journal of natural products, Aug, Volume: 65, Issue:8
Gaboroquinones A and B and 4'-O-demethylknipholone-4'-O-beta-D-glucopyranoside, phenylanthraquinones from the roots of Bulbine frutescens.
AID1062996Cytotoxicity against human A2780 cells2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Isolation of antiplasmodial anthraquinones from Kniphofia ensifolia, and synthesis and structure-activity relationships of related compounds.
AID356062Cytotoxicity against human HPC by MTT assay2003Journal of natural products, Jun, Volume: 66, Issue:6
Bulbinelonesides A-E, phenylanthraquinone glycosides from the roots of Bulbinella floribunda.
AID1858848Antimalarial activity against Plasmodium falciparum K1 by 96-well microtitre plate method based scintillation counting analysis2021European journal of medicinal chemistry, Jan-15, Volume: 210Antimalarial application of quinones: A recent update.
AID1304533Antimalarial activity against multidrug resistant Plasmodium falciparum NHP1337 assessed as growth inhibition after 72 hrs by SYBR Green based fluorescence assay2016Journal of natural products, Mar-25, Volume: 79, Issue:3
Identification of Compounds with Efficacy against Malaria Parasites from Common North American Plants.
AID1304534Resistance index, ratio of IC50 for multidrug resistant Plasmodium falciparum NHP1337 to IC50 for multidrug sensitive Plasmodium falciparum HB32016Journal of natural products, Mar-25, Volume: 79, Issue:3
Identification of Compounds with Efficacy against Malaria Parasites from Common North American Plants.
AID335833Trypanocidal activity against trypomastigotes of Trypanosoma cruzi Tulahuen C2C4 infected in rat L6 cells after 4 days2002Journal of natural products, Aug, Volume: 65, Issue:8
Gaboroquinones A and B and 4'-O-demethylknipholone-4'-O-beta-D-glucopyranoside, phenylanthraquinones from the roots of Bulbine frutescens.
AID1304535Cytotoxicity against human HeLa cells assessed as growth inhibition by sulforhodamine B assay2016Journal of natural products, Mar-25, Volume: 79, Issue:3
Identification of Compounds with Efficacy against Malaria Parasites from Common North American Plants.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (7.14)18.2507
2000's7 (50.00)29.6817
2010's3 (21.43)24.3611
2020's3 (21.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.59 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index5.30 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]